Blood Screening Market Set to Surge at Impressive 8.2 % CAGR Through 2032

Blood Screening Market

As per a recent study released by Maximize Market Research, titled, “Blood Screening Market,” The Blood Screening Market, with its value estimated at approximately USD 3.15 billion in 2024 and poised to grow at an impressive 8.2 % compound annual growth rate (CAGR) from 2025 through 2032. Market projections indicate that by 2032, the market could nearly reach USD 5.93 billion.

Blood Screening Market Overview:

In recent years, blood screening has evolved from traditional serological testing to more sophisticated molecular technologies, including nucleic acid amplification tests (NAT) and next-generation sequencing (NGS). These advancements enhance sensitivity and reduce the detection window for critical pathogens such as HIV, hepatitis B and C, and emerging infectious agents.

The market is also benefitting from the increasing volume of blood transfusion procedures globally. Amid heightened awareness of healthcare safety and stringency in regulations, stakeholders are prioritizing investments in reagents, kits, and automation platforms to maintain the integrity and reliability of the blood supply.

Download a Free Sample Report Today : https://www.maximizemarketresearch.com/request-sample/13686/ 

Blood Screening Market Dynamics

Dynamic forces are shaping this market from multiple angles. First, the implementation of stricter regulatory guidelines worldwide and growing public health initiatives to promote safe blood donation have elevated the demand for high-accuracy screening tools. Institutions are increasingly transitioning toward molecular diagnostics to mitigate the risks associated with transfusion-transmitted infections and enhance overall screening protocols.

Second, rapid technological innovation—particularly in automated molecular platforms—has transformed the competitive landscape. Vendors are launching streamlined, high-throughput NAT systems and multiplexed reagent kits, enabling faster, more reliable screening processes. These advancements not only reduce labor and time costs but also appeal to blood banks and hospital laboratories aiming to scale up capabilities while maintaining operational efficiency.

Blood Screening Market Outlook and Future Trends :

Looking forward, the blood screening market is poised for further expansion with an accelerated shift toward integrated automation and multiplexed diagnostic systems. These advancements will empower screening facilities to process more samples with enhanced accuracy, reinforcing their ability to safeguard against emerging and evolving pathogens.

Moreover, the integration of artificial intelligence and data analytics is expected to refine diagnostic precision, alert clinicians to irregular patterns more quickly, and facilitate predictive monitoring of blood-borne threats. Coupled with increasing investments by both private and public health sectors in screening infrastructure, the market is well positioned to evolve into a smarter, more proactive system that prioritizes both speed and safety.

Blood Screening Market Regional Insights:

Geographically, North America continues to lead the blood screening market thanks to its strong healthcare infrastructure, high donor participation rates, and rapid adoption of molecular diagnostic technologies. Stability in regulatory frameworks and continuous innovation further solidify its dominant position. Other regions—particularly Europe and Asia Pacific—are witnessing accelerated growth as awareness around blood safety intensifies, healthcare spending increases, and emerging economies invest in diagnostic modernization to support expanding transfusion services.

Blood Screening Market Segmentation

by Technology

Nucleic Acid Test (NAT)
Transcription-mediated Amplification (TMA)
Real-time Polymerase Chain Reaction (PCR)
Enzyme-linked Immunosorbent Assay (ELISA)
By Platform
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FIA)
Colorimetric Immunoassay (CI)
By Generation
First Generation
Second Generation
Third Generation
Fourth Generation & Above
Rapid Tests
Western Blot Assay
Next-generation Sequencing (NGS)

by Product & Service

Reagents & Kits
NAT Reagents & Kits
Enzymes and Polymerases
Standards and Controls
Probes and Primers
Buffers, Nucleotides, and Solutions
Labeling and Detection Reagents
ELISA Reagents & Kits
Immunosorbents
Controls
Conjugates
Substrates
Sample Diluents and Wash Solutions
Other Reagents & Kits
Instruments
Rental Purchase
Outright Purchase
Software and Services

by End User

Blood Banks
Hospitals

Some of the current players in the Blood Screening Market are:

1. Abbott Laboratories
2. Thermo Fisher Scientific, Inc.
3. Bio-Rad Laboratories, Inc
4. Becton, Dickinson, and Company
5. asima
6. Enzo Biochem Inc
7. Mirvie
8. Hologic Inc
9. Grifols
10. Roche Diagnostics

About Maximize Market Research: 

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.
  ⮝ 3rd Floor, Navale IT park Phase 2,
  Pune Banglore Highway, Narhe
  Pune, Maharashtra 411041, India.
  ✆ +91 9607365656
🖂 [email protected]

Maximize Market Research

Maximize Market Research

As an approved news provider, vetted by the Newstrail editorial board, Maximize Market Research is a world leader in market research and analysis, sharing B2B and B2C research insights globally.